Advertisement

Drug Research and Drug Development in the 21st Century

Science and Ethics

  • H.-P. Wolff
  • A. Fleckenstein
  • E. O. Philipp
Conference proceedings

Part of the Bayer AG Centenary Symposium book series (BAYER)

Table of contents

  1. Front Matter
    Pages I-XII
  2. History and Philosophy of Bayer Pharmaceutical Research

  3. Science, Responsibility, and Society

    1. K. Heilmann
      Pages 9-15
  4. Opening Remarks

    1. A. Fleckenstein
      Pages 16-18
  5. Message of Greeting

    1. R. Süßmuth
      Pages 19-19
  6. Unresolved Problems of Chronic Diseases

    1. Front Matter
      Pages 21-21
    2. G. Schettler, A. J. R. Habenicht
      Pages 34-42
    3. S. Corkin
      Pages 53-61
    4. H. Herzog
      Pages 62-89
    5. H. F. Oettgen
      Pages 90-104
    6. Challenges and Obstacles in Clinical Evaluations of Therapy

    7. Back Matter
      Pages 123-138
  7. Advanced Technologies, Scientific Achievements

    1. Front Matter
      Pages 139-139
    2. Receptors and Messengers

      1. G. Assmann, H. Funke, G. Schmitz
        Pages 141-161
      2. P. J. Piper
        Pages 162-171
    3. Drug Design

      1. E. Mutschler
        Pages 172-172
      2. W. G. J. Hol
        Pages 183-191
    4. Analytical Pathophysiology and Biochemistry

      1. W. F. Caspary
        Pages 200-200
      2. C. G. Gottfries
        Pages 201-213
      3. J. J. Killion, I. J. Fidler
        Pages 214-223
      4. H.-P. Wolff, A. Fleckenstein, E. O. Philipp
        Pages 224-238
    5. The Patient as a Subject to Medical Research

    6. Back Matter
      Pages 284-302
  8. Back Matter
    Pages 305-310

About these proceedings

Introduction

Distinguished scientists and members of the medical profession discuss the research and development of safe and suitable drugs for the long-term treatment of chronic diseases. The book provides an up-to-date survey on new insights and technologies - as well as ethical considerations - , since traditional means and methods of drug research and drug development may no longer suffice to meet the challenges of the next century.

Keywords

Alzheimer Lipoprotein biochemistry brain clinical trial diseases drug drug development drug research ethics inflammation neurotransmitter pathophysiology physiology research

Editors and affiliations

  • H.-P. Wolff
    • 1
  • A. Fleckenstein
    • 2
  • E. O. Philipp
    • 3
  1. 1.Wissenschaftlicher Beirat der BundesärztekammerMaria Alm/HinterthalAustria
  2. 2.Physiologisches InstitutUniversität FreiburgFreiburgFederal Republic of Germany
  3. 3.PH-Forschungszentrum, ZPM/ProjektmanagerBayer AGWuppertalFederal Republic of Germany

Bibliographic information

  • DOI https://doi.org/10.1007/978-3-642-74615-4
  • Copyright Information Springer-Verlag Berlin Heidelberg 1989
  • Publisher Name Springer, Berlin, Heidelberg
  • eBook Packages Springer Book Archive
  • Print ISBN 978-3-540-50961-5
  • Online ISBN 978-3-642-74615-4
  • Series Print ISSN 1431-116X
  • Buy this book on publisher's site